1. Haute Autorité de Santé (HAS); Agence nationale de sécurité du médicament et des produits de santé (Ansm). Stratégie médicamenteuse du contrôle glycémique du diabète de type 2. Recommandation de bonne pratique. Janvier 2013. http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-02/10irp04_reco_diabete_type_2.pdf.
2. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes;Inzucchi;Diabetes Care,2015
3. National Institute for Health and Care Excellence (NICE). Type 2 diabetes in adults: management. NICE guideline [NG28]. Published: December 2015. Last updated: July 2016. https://www.nice.org.uk/guidance/ng28
4. 8. Pharmacological approaches to glycemic treatment. In: Standards of Medical Care in Diabetes--2017;Diabetes Care,2017
5. Estimating the incremental net health benefit of requirements for cardiovascular risk evaluation for diabetes therapies;Chawla;Pharmacoepidemiol Drug Saf,2014